[EN] FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS [FR] DERIVES HETEROARYLE CONDENSES UTILISABLES COMME INHIBITEURS DE KINASE P38, NOTAMMENT DANS LE TRAITEMENT DE POLYARTHRITE RHUMATOIDE
[EN] FUSED HETEROYRAL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS<br/>[FR] DERIVES HETEROARYL FUSIONNES A UTILISER EN TANT QU'INHIBITEURS DE LA KINASE P38
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2005073189A1
公开(公告)日:2005-08-11
Compounds of formula (I) are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
[EN] HETEROARYL SUBSTITUTED BIPHENYL DERIVATIVES AS P38 KINASE INHIBITORS<br/>[FR] DERIVES DE BIPHENYL SUBSTITUES EN HETEROARYLE SOUS FORME D'INHIBITEURS DE P38 KINASE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2003093248A1
公开(公告)日:2003-11-13
Compounds of formula (I) are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
[EN] P38 KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA KINASE P38
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2005073232A1
公开(公告)日:2005-08-11
Compounds of Formula: (I) are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
[EN] BIPHENYL CARBOXYLIC AMIDE P38 KINASE INHIBITORS<br/>[FR] AMIDE BIPHENYLE CARBOXYLIQUE UTILISES EN TANT QU'INHIBITEURS DE LA KINASE P38
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2004089874A1
公开(公告)日:2004-10-21
Compounds of formula (I) or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
式(I)的化合物或其药用可接受的衍生物,以及它们作为药物的用途,特别是作为p38激酶抑制剂。
[EN] FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRITIS<br/>[FR] DERIVES D'HETEROARYLE FUSIONNES UTILISES EN TANT QU'INHIBITEURS DE KINASE P38 DANS LE TRAITEMENT DE LA POLYARTHRITE RHUMATOIDE, ENTRE AUTRES
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2005073219A1
公开(公告)日:2005-08-11
Compounds of formula: (I) are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.